SKP2 and melanoma: In our studies, FKA downregulated the protein expression of Skp2 in all tested cancer cell lines that were derived from prostate, breast, renal, liver, lung, colon, and cervical cancers, melanoma and osteosarcoma, regardless of their genetic background [18].